Agustin Bengolea

Dr. Agustin Bengolea

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2020 in medRxiv
Verified
Preprint
Open access
PDF file
AIAriel Izcovich
Ariel Izcovich
MRMartín Ragusa
Martín Ragusa
VSVerónica Sanguine
Verónica Sanguine
FTFernando Tortosa
Fernando Tortosa
FEFederico Espinosa
Federico Espinosa
CGCOVID-19 L·OVE Working Group
COVID-19 L·OVE Working Group
Objective The objective of our systematic review is to identify prognostic factors that can potentially be used in decision-making related to the care of patients infected with COVID-19. Design This is the protocol of a living systematic review. Data sources We will conduct searches in PubMed/Medline, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), grey literature and in a centralised repository in L·OVE (Living OVerview of Evidence). L·OVE is a platform that maps PICO questions to evidence from Epistemonikos database. In response to the COVID-19 emergency, L·OVE was adapted to expand the range of evidence covered and customised to group all COVID-19 evidence in one place. The search will continue until the day before submission to a journal. Eligibility criteria for selecting studies and methods We will follow a common protocol for multiple parallel systematic reviews, already published and submitted to PROSPERO (awaiting ID allocation). We will include studies that assess patients with confirmed or suspected SARS-CoV-2 infection and inform the relation between potential prognostic factors and death or disease severity. Two groups of two reviewers will independently screen studies for eligibility, extract data and assess the risk of bias. We will perform meta-analyses and use GRADE to assess the certainty of evidence for each prognostic factor and outcome. A living, web-based version of this review will be openly available during the COVID-19 pandemic. We will resubmit it if the conclusions change or there are substantial updates. Ethics and dissemination No ethics approval is considered necessary. The results of this review will be widely disseminated via peer-reviewed publications, social networks and traditional media. PROSPERO Registration Submitted to PROSPERO (awaiting ID allocation).

22 May 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ABAgustin Bengolea
Agustin Bengolea
JRJuan I. Ruiz
Juan I. Ruiz
CVCelina G. Vega
Celina G. Vega
MMMatias Manzotti
Matias Manzotti
NZNadia Zuccarino
Nadia Zuccarino
LRLucila Rey-Ares
Lucila Rey-Ares
Objective: To describe the hospital medical resources used in adults hospitalized with respiratory syncytial virus infection and to evaluate the association of comorbidities with resource utilization and clinical outcomes. Design: A retrospective cohort study was conducted using the electronic healthcare database of Hospital Alemán, Buenos Aires, Argentina. It included hospitalized patients aged 18 years or older who had a positive test for respiratory syncytial virus between September 2010 and December 2023. Data were analyzed using standard statistical methods following STROBE guidelines. Results: Among 72 hospitalized adults with confirmed respiratory syncytial virus infection, the mean length of hospital stay was 12.18 days (SD 12.91), and 27 (37.5%) patients required intensive care unit admission. Healthcare resource utilization was substantial, with 26% needing non-invasive ventilation and 11% requiring mechanical ventilation. Antibiotics (75%) and corticosteroids (68.05%) were commonly used, likely reflecting the severity of clinical presentation or the potential for bacterial coinfection. Cardiovascular comorbidities were significantly associated with severe disease outcomes and intensive care unit admission (OR 3.53, 95% CI: 1.00–12.54). Comparative analysis with 226 influenza patients showed respiratory syncytial virus patients had longer hospital stays and higher intensive care unit admission rates. Conclusions: Respiratory syncytial virus infection in adults resulted in substantial medical resource utilization and significant intensive care unit admission and ventilation support requirements. Cardiovascular comorbidities might be associated with increased severity and intensive care unit admissions. The high rate of antibiotic use is noteworthy and warrants further investigation to understand prescribing patterns and optimize antimicrobial stewardship. Compared to influenza, respiratory syncytial virus appears to be associated with longer hospital stays and higher intensive care unit admissions, highlighting the need for tailored management strategies for respiratory syncytial virus in adult populations. Further research should focus on optimizing treatment protocols and preventive measures for respiratory syncytial virus.

1 July 2024
Verified
Journal Article
Closed access
ABAgustin Bengolea
Agustin Bengolea
CSClara Scigliano
Clara Scigliano
JRJose T. Ramos-Rojas
Jose T. Ramos-Rojas
GRGabriel Rada
Gabriel Rada
HCHugo N. Catalano
Hugo N. Catalano
AIAriel Izcovich
Ariel Izcovich

9 May 2025 in Journal of Clinical Epidemiology
Verified
Journal Article
Open access
CZCarlos Zaror
Carlos Zaror
MKMaura Klenner-Loebel
Maura Klenner-Loebel
YSYang Song
Yang Song
TAThomas Agoritsas
Thomas Agoritsas
GBGiselle Balaciano
Giselle Balaciano
RBRomina Brignardello-Petersen
Romina Brignardello-Petersen
We assessed the perceptions about a new methodological process to translate and adapt the World Health Organization living guidelines for COVID-19 recommendations for therapeutics in Argentina from the guideline development group's (GDG) perspective. A tailored adaptation process, linked to a prototype tool and created as part of the GATEWAY project by the MAGIC Evidence Ecosystem Foundation, starts by assessing the recommendation and justification and then examining evidence to decision factors. We focused our evaluation on the adaptation process steps carried out from December 2022 to June 2023. We collected information through (1) observations of the panel meeting, (2) focus group with methods team, (3) semistructured interviews with panel members, (4) postpanel meeting survey, and (5) a satisfaction survey. We carried out descriptive analyses of surveys and content analysis of focus groups and interviews. GDG adapted four recommendations, of which two were modified in direction or strength and elaborated one de novo. The survey showed that most GDG members found the training session (89%) and prepanel meeting survey (100%) facilitated adaptation. Focus groups and interviews showed that GDG agreed that the process considered the relevant local factors to adapt the recommendations and that it was transparent and easy to understand, allowing it to reach a consensus efficiently. GDG valued the process's flexibility and time optimization. They considered the premeeting survey analysis crucial in facilitating the consensus. From the GDG perspective, this case study demonstrated that this tailored approach provides a transparent, efficient, and rigorous methodology for translating and adapting the World Health Organization living guidelines for COVID-19.

29 October 2024 in medRxiv
Verified
Preprint
Open access
PDF file
ABAgustin Bengolea
Agustin Bengolea
JRJuan I Ruiz
Juan I Ruiz
CVCelina G. Vega
Celina G. Vega
MMMatias Manzotti
Matias Manzotti
NZNadia Zuccarino
Nadia Zuccarino
LALucila Rey Ares
Lucila Rey Ares
Objective: To describe the hospital medical resources used in adults hospitalized with respiratory syncytial virus infection and to evaluate the association of comorbidities with resource utilization and clinical outcomes. Design: A retrospective cohort study was conducted using the electronic healthcare database of Hospital Alemán, Buenos Aires, Argentina. It included hospitalized patients aged 18 years or older who had a positive test for respiratory syncytial virus between September 2010 and December 2023. Data were analyzed using standard statistical methods following STROBE guidelines. Results: Among 72 hospitalized adults with confirmed respiratory syncytial virus infection, the mean length of hospital stay was 12.18 days (SD 12.91), and 27 (37.5%) patients required intensive care unit admission. Healthcare resource utilization was substantial, with 26% needing non-invasive ventilation and 11% requiring mechanical ventilation. Additionally, 75% received antibiotics, and 68.05% were treated with corticosteroids. Cardiovascular comorbidities were significantly associated with severe disease outcomes and intensive care unit admission (OR 3.53, 95% CI: 1.00-12.54). Comparative analysis with 226 influenza patients showed respiratory syncytial virus patients had longer hospital stays and higher intensive care unit admission rates. Conclusions: Respiratory syncytial virus infection in adults resulted in substantial medical resource utilization and significant intensive care unit admission and ventilation support requirements. Cardiovascular comorbidities are associated with increased severity and intensive care unit admission admissions. Compared to influenza, respiratory syncytial virus leads to longer hospital stays and higher intensive care unit admissions, highlighting the need for tailored management strategies for respiratory syncytial virus in adult populations. Further research should focus on optimizing treatment protocols and preventive measures for respiratory syncytial virus.

1 September 2024
Verified
Journal Article
Closed access
ABAgustin Bengolea
Agustin Bengolea
FCFlorencia Chamorro
Florencia Chamorro
JRJose t. Ramos
Jose t. Ramos
GRGabriel Rada
Gabriel Rada
HCHugo n. Catalano
Hugo n. Catalano
AIAriel Izcovich
Ariel Izcovich